
The Library
Browse by Warwick Author
![]() | Up a level |
Number of items: 19.
2022
Ramasamy, Karthik, Iqbal, Gulnaz, Brouwer, Richard, Stalker, Victoria, Akhtar, Salma, Varghese, Sherin, Lindsay, Jindriska, Schey, Stephen, Drayson, Mark and Dunn, Janet (2022) Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL) : a randomised, multi-centre phase II trial. Blood Cancer Journal, 12 . 162. doi:10.1038/s41408-022-00758-7
Agbuduwe, Charles, Iqbal, Gulnaz, Cairns, David, Menzies, Tom, Dunn, Janet A., Gregory, Walter, Kaiser, Martin, Owen, Roger, Pawlyn, Charlotte, Child, J. Anthony, Davies, Faith, Morgan, Gareth J., Jackson, Graham H., Drayson, Mark T. and Basu, Supratik (2022) Clinical characteristics and outcomes of IgD myeloma : experience across UK national trials. Blood Advances, 6 (17). pp. 5113-5123. doi:10.1182/bloodadvances.2022007608
2019
Drayson, Mark T., Bowcock, Stella, Planche, Tim, Iqbal, Gulnaz, Pratt, Guy, Yong, Kwee, Wood, Jill, Raynes, Kerry, Higgins, Helen, Dawkins, Bryony, Meads, David, Hulme, Claire T., Whittaker, Anna C., Hawkey, Peter, Low, Eric and Dunn, Janet A. (2019) Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT. Health Technology Assessment, 23 (62). pp. 1-94. doi:10.3310/hta23620
Drayson, Mark T, Bowcock, Stella, Planche, Tim, Iqbal, Gulnaz, Pratt, Guy, Yong, Kwee, Wood, Jill, Raynes, Kerry, Higgins, Helen B., Dawkins, Bryony et al.
(2019)
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM) : a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
The Lancet. Oncology, 20
(12).
pp. 1760-1772.
doi:10.1016/S1470-2045(19)30506-6
Dunn, Janet A., Jefferson, Kieran, MacDonald, Donald, Iqbal, Gulnaz and Bland, Rosemary (2019) Low serum 25-hydroxyvitamin D is associated with increased bladder cancer risk: A systematic review and evidence of a potential mechanism. The Journal of Steroid Biochemistry and Molecular Biology, 188 . pp. 134-140. doi:10.1016/j.jsbmb.2019.01.002
2018
Heaney, Jennifer L. J.,, Campbell, John P., Iqbal, Gulnaz, Cairns, David, Richter, Alex, Child, J. Anthony, Gregory, Walter, Jackson, Graham, Kaiser, Martin, Owen, Roger, Davies, Faith, Morgan, Gareth, Dunn, Janet A. and Drayson, Mark T. (2018) Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials. Leukemia, 32 . pp. 1727-1738. doi:10.1038/s41375-018-0163-4
Chicca, I. J., Heaney, J. L. J., Iqbal, Gulnaz, Bowcock, S., Planche, T., Wood, J., Raynes, K., Hawkey, P., Pratt, G., Yong, K., Dunn, Janet A. and Drayson, M. T. (2018) Major changes in levels of regulatory cytokines and functional antibodies contribute to severe immunodeficiency of myeloma patients and persist at one year post diagnosis. Haematologica, 103 (Supplement 1). pp. 1-48. P02.
Bowcock, S., Atkin, C., Iqbal, Gulnaz, Yong, K., Pratt, G., Planche, T., Wood, J., Raynes, K., Hawkey, P., Dunn, Janet A., Drayson, M. and Co-Investigators, Teamm (2018) Does a long diagnostic pathway in myeloma lead to more advanced disease at presentation? An analysis from the TEAMM trial (Tackling EArly Morbidity and Mortality in Myeloma). British Journal of Haematology, 181 (Supplement 1). pp. 5-211. BSH18-PO-098 [pp 99]. doi:10.1111/bjh.15226
Bowcock, S., Planche, T., Iqbal, Gulnaz, Pratt, G., Yong, K., Wood, J., Raynes, K., Hawkey, P., Dunn, Janet A., Drayson, M. and Co-Investigators, Teamm (2018) Levofloxacin prophylaxis in newly diagnosed myeloma reduces febrile episodes and death without increasing healthcare associated infections : results from the TEAMM trial (Tackling EArly Morbidity and Mortality in Myeloma). British Journal of Haematology, 181 (Supplement 1). pp. 5-211. BSH18-OR-012 [pp16]. doi:10.1111/bjh.15226
Atkin, C., Drayson, M., Iqbal, Gulnaz, Yong, K., Pratt, G., Planche, T., Wood, J., Raynes, K., Higgins, Helen B., Dunn, Janet A. and Bowcock, S. (2018) Presenting symptoms of patients with multiple myeloma : data from the TEAMM (Tackling EArly Morbidity and Mortality in Myeloma) trial. British Journal of Haematology, 181 (Supplement 1). pp. 5-211. BSH18-PO-094 [pp 96]. doi:10.1111/bjh.15226
2015
Mistry, Pankaj, Hiller, Louise, Iqbal, Gulnaz and Dunn, Janet A. (2015) Under-representation of male patients in breast cancer studies. Trials, 16 (Supplement 2). P110. doi:10.1186/1745-6215-16-S2-P110
Dunn, Janet A., Harris, B., Iqbal, Gulnaz, Wood, J., Mistry, Pankaj, O'Beirne-Elliman, J., Bowcock, S. and Drayson, M. (2015) Use of patient diaries in conjunction with standard reporting methods : duplication of data or a valuable resource? Trials, 16 (Supplement 2). P183.
Bryan, R. T., Evans, T., Dunn, Janet A., Iqbal, Gulnaz, Bathers, S., Collins, S. I., James, Nicholas D., Catto, J. W. F. and Wallace, D. M. A. (2015) A comparative analysis of the influence of gender, pathway delays, and risk factor exposures on the long-term outcomes of bladder cancer. European Urology Focus, 1 (1). pp. 82-89. doi:10.1016/j.euf.2015.01.001
2014
Molyneux, Elizabeth, Merrick, Blair, Khanim, Farhat L., Banda, Kondwani, Dunn, Janet A., Iqbal, Gulnaz, Bunce, Christopher M. and Drayson, Mark T. (2014) Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi ; an open-label, single-arm, phase 2 study (ISRCTN34303497). British Journal of Haematology, Volume 164 (Number 6). pp. 888-890. doi:10.1111/bjh.12681
2013
Iqbal, Gulnaz (2013) Improving ethnicity data collection and ethnic minority participation in randomised clinical trials. PhD thesis, University of Warwick.
Bryan, Richard T., Zeegers, Maurice P., van Roekel, Eline H., Bird, Deborah, Grant, Margaret R., Dunn, Janet A., Bathers, Sarah, Iqbal, Gulnaz, Khan, Humera S., Collins, Stuart I., Howman, Andrew, Deshmukh, Nayneeta S., James, Nicholas D., Cheng, Kar Keung and Wallace, D. Michael A. (2013) A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years. BJU International, Volume 112 (Number 2). pp. 169-175. doi:10.1111/bju.12032
2012
Iqbal, Gulnaz, Johnson, Mark R. D., Szczepura, Ala, Gumber, Anil, Wilson, Sue and Dunn, Janet A. (2012) Ethnicity data collection in the UK: The healthcare professional's perspective. Diversity and equality in health and care, 9 (4). pp. 281-290.
Iqbal, Gulnaz, Johnson, Mark R. D., Szczepura, Ala, Wilson, Sue, Gumber, Anil and Dunn, Janet A. (2012) UK ethnicity data collection for healthcare statistics : the South Asian perspective. BMC Public Health, Vol.12 (No.1). p. 243. doi:10.1186/1471-2458-12-243
2009
WARP Collaborat Grp UK (Including: Young, Annie M., Billingham, Lucinda J., Begum, Gulnaz, Kerr, David J., Hughes, Ana I., Rea, Daniel W., Shepherd, Stephen, Stanley, Andrew, Sweeney, Ann, Wilde, Jonathan and Wheatley, Keith). (2009) Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP) : an open-label randomised trial. Lancet, Vol.373 (No.9663). pp. 567-574. doi:10.1016/S0140-6736(09)60205-1
This list was generated on Sat Jan 28 11:40:25 2023 GMT.